Active surveillance an evolving approach for low-risk prostate cancer

Article

In this interview, Laurence Klotz, MD, discusses his group's active surveillance protocol for men with favorable-risk prostate cancer, which men are candidates, how they are monitored, and triggers for active treatment.

Related Videos
Conference of doctors | Image Credit:  ©  Aydan - stock.adobe.com
Experts on prostate cancer
Experts on prostate cancer
Udit Singhal, MD, answers a question during a zoom video interview
Randall A. Lee, MD, answers a question during a Zoom video interview
Expert on prostate cancer
Related Content
© 2023 MJH Life Sciences

All rights reserved.